Revenue: The sum of all revenue fields included for a company's operating activities.
AngioDynamics, Inc. (ANGO) had Revenue of $292.50M for the most recently reported fiscal year, ending 2025-05-31.
| Income Statement Financials | |
|
Revenue |
$292.50M |
$-33.99M |
|
$134.79M |
|
$157.71M |
|
$332.45M |
|
$-39.95M |
|
$5.92M |
|
$-34.03M |
|
$-34.03M |
|
$-33.99M |
|
$-33.99M |
|
$-33.99M |
|
$-33.99M |
|
$-39.95M |
|
$-14.15M |
|
40.85M |
|
40.85M |
|
$-0.83 |
|
$-0.83 |
|
| Balance Sheet Financials | |
$168.32M |
|
$32.30M |
|
$111.82M |
|
$280.14M |
|
$76.20M |
|
-- |
|
$20.98M |
|
$97.17M |
|
$182.97M |
|
$113.85M |
|
$182.97M |
|
40.99M |
|
| Cash Flow Statement Financials | |
$-10.13M |
|
$-10.18M |
|
$-0.26M |
|
$76.06M |
|
$55.89M |
|
$-20.16M |
|
$9.77M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.21 |
|
-- |
|
-- |
|
-- |
|
-- |
|
53.92% |
|
-13.66% |
|
-13.66% |
|
-4.84% |
|
-11.63% |
|
-11.62% |
|
$-14.59M |
|
-- |
|
-- |
|
-- |
|
1.04 |
|
2.17 |
|
6.82 |
|
53.52 |
|
-18.58% |
|
-29.86% |
|
-12.13% |
|
-18.58% |
|
$4.46 |
|
$-0.36 |
|
$-0.25 |
|